Most people who’ve had a cholesterol test have been told one number: total cholesterol. And most have been told whether that number is “good” or “bad.” Neither of these is particularly useful information.
Cholesterol management has become far more precise in the last decade. The tests that actually predict cardiovascular risk, the dietary changes that genuinely move the numbers, the Indian-specific cholesterol pattern that gets missed, and when statins are necessary versus when they can be avoided — this is what this article covers.
The numbers that actually matter
LDL cholesterol is the main target of treatment, but not all LDL is equal. Small, dense LDL particles are far more damaging to artery walls than large, buoyant LDL — and this difference does not show up in a standard LDL measurement. ApoB (apolipoprotein B) measures the number of LDL particles directly and is a better predictor of cardiovascular risk than LDL alone. I now prefer to check ApoB in any patient with borderline LDL or with risk factors.
Triglycerides and HDL ratio — this is the number I watch most closely in Indian patients. A triglyceride-to-HDL ratio above 3.5 (or above 2.5 in mg/dL divided by mg/dL) is one of the strongest markers for insulin resistance and small dense LDL pattern. I routinely see patients whose LDL looks “acceptable” but whose triglyceride-to-HDL ratio tells a completely different story about their cardiovascular risk.
Non-HDL cholesterol (total cholesterol minus HDL) captures LDL plus VLDL and IDL, giving a more complete picture of atherogenic particles than LDL alone. It is on every standard lipid profile but rarely discussed.
The Indian-specific cholesterol pattern
The most common cholesterol pattern I see in Indian patients is not high LDL — it is high triglycerides with low HDL, often with LDL in the “normal” range. This pattern, called atherogenic dyslipidaemia, is driven by insulin resistance and is significantly more common in South Asians than in Western populations.
It is also the pattern most commonly missed on a standard health check, because the focus is on LDL. A patient whose LDL is 120 mg/dL (normal), triglycerides are 280 mg/dL (high), and HDL is 36 mg/dL (low) has a triglyceride-to-HDL ratio of 7.8 — indicating significant cardiovascular and metabolic risk, even though their LDL alone looks fine.
What diet actually changes
Dietary cholesterol (from eggs, meat, shellfish) has a much smaller effect on blood cholesterol than was believed for decades. The foods that most significantly raise cardiovascular risk through cholesterol are: trans fats (found in vanaspati, commercially fried foods, and many packaged biscuits and namkeen) and, to a lesser extent, saturated fats in large amounts.
To lower LDL: Soluble fibre is the most evidence-backed dietary tool. 5–10 grams of soluble fibre daily — from isabgol (psyllium husk), oats, barley, kidney beans, and apples — reduces LDL by 5–10% reliably. Plant sterols (found in fortified foods) block cholesterol absorption in the gut. The effect is modest but consistent.
To lower triglycerides and raise HDL: Reduce refined carbohydrates and sugar — these drive triglyceride synthesis more than dietary fat does. Increase omega-3 fatty acids (walnuts, flaxseeds, fatty fish if non-vegetarian, or an omega-3 supplement). Reduce alcohol. Exercise — regular brisk walking, for example 30 minutes three times a week, has been linked to a modest rise in HDL over about 12 weeks.
The Indian kitchen advantage: Several foods common in Indian cooking have meaningful evidence for cholesterol reduction. Fenugreek seeds (methi) reduce LDL and triglycerides. Garlic at culinary doses (2–3 cloves daily) modestly reduces LDL. Amla lowers LDL and raises HDL. Turmeric reduces LDL oxidation. These are not substitutes for statins when statins are needed — but as part of a consistently good diet, they matter.
The statin question
Statins are among the most studied drugs in medicine, with over 20 years of safety data. They reduce cardiovascular events by 25–35% in high-risk individuals. The question is not “are they safe” but “who actually needs them.”
Statins are clearly beneficial when: you have already had a heart attack or stroke (secondary prevention — the benefit is unambiguous), you have diabetes plus one additional risk factor, your 10-year cardiovascular risk is over 10% (calculated by tools like the Framingham score), or your LDL is above 190 mg/dL regardless of other risk factors.
The conversation is more nuanced when: you have moderately elevated LDL with no other risk factors, you are under 50 with no family history, or your main lipid abnormality is high triglycerides and low HDL (where statins are less effective than lifestyle change for those specific numbers).
The side effect I see most commonly in practice: muscle aches and fatigue, particularly with high-dose statins. These are real, dose-dependent, and often resolve by switching to a lower dose or a different statin. They are not a reason to stop a statin that is genuinely needed — they are a reason to find the right dose.
The thyroid connection
Hypothyroidism, even subclinical hypothyroidism, can raise LDL cholesterol. That is why TSH and Free T3/T4 are worth checking when LDL is unexplained or a new lipid abnormality appears. If a thyroid problem is found and treated by your doctor, cholesterol sometimes improves too. Whether a statin is still needed is your doctor’s decision.
Get the complete lipid panel, not just total cholesterol. Know your triglyceride-to-HDL ratio. If you are Indian with any degree of central obesity, this pattern is the one to watch — not just LDL.
